The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2020-09, Vol.34 (9), p.2479-2483
Hauptverfasser:	Godwin, Colin D., Laszlo, George S., Wood, Brent L., Correnti, Colin E., Bates, Olivia M., Garling, Eliotte E., Mao, Zhengwei J., Beddoe, Mary E., Lunn, Margaret C., Humbert, Olivier, Kiem, Hans-Peter, Walter, Roland B.
Format:	Artikel
Sprache:	eng
Schlagworte:	13 13/1 13/106 13/31 13/44 13/51 14 14/1 14/19 42 631/67/1990/283/1897 692/699/67/1059/2325 Acute myeloid leukemia Antibody Specificity Cancer Research Cell Separation Critical Care Medicine Exons Flow Cytometry Health aspects Hematology Humans Intensive Internal Medicine Letter Leukemia Leukemia, Myeloid, Acute - immunology Leukemia, Myeloid, Acute - therapy Medical research Medicine Medicine & Public Health Medicine, Experimental Myeloid leukemia Oncology Protein Isoforms - genetics Protein Splicing Sialic Acid Binding Ig-like Lectin 3 - immunology Sialic Acid Binding Ig-like Lectin 3 - metabolism Therapeutic targets Tumor Cells, Cultured
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!